501 related articles for article (PubMed ID: 16806436)
21. Surgery in recurrent ovarian cancer: the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR trial.
Harter P; du Bois A; Hahmann M; Hasenburg A; Burges A; Loibl S; Gropp M; Huober J; Fink D; Schröder W; Muenstedt K; Schmalfeldt B; Emons G; Pfisterer J; Wollschlaeger K; Meerpohl HG; Breitbach GP; Tanner B; Sehouli J; ;
Ann Surg Oncol; 2006 Dec; 13(12):1702-10. PubMed ID: 17009163
[TBL] [Abstract][Full Text] [Related]
22. Secondary cytoreductive surgery for isolated nodal recurrence in patients with epithelial ovarian cancer.
Santillan A; Karam AK; Li AJ; Giuntoli R; Gardner GJ; Cass I; Karlan BY; Bristow RE
Gynecol Oncol; 2007 Mar; 104(3):686-90. PubMed ID: 17141302
[TBL] [Abstract][Full Text] [Related]
23. Prognostic factors and role of salvage surgery in chemorefractory ovarian germ cell malignancies: a study in Chinese patients.
Li J; Yang W; Wu X
Gynecol Oncol; 2007 Jun; 105(3):769-75. PubMed ID: 17459461
[TBL] [Abstract][Full Text] [Related]
24. CA125 level as a predictor of progression-free survival and overall survival in ovarian cancer patients with surgically defined disease status prior to the initiation of intraperitoneal consolidation therapy.
Juretzka MM; Barakat RR; Chi DS; Iasonos A; Dupont J; Abu-Rustum NR; Poynor EA; Aghajanian C; Spriggs D; Hensley ML; Sabbatini P
Gynecol Oncol; 2007 Jan; 104(1):176-80. PubMed ID: 16996584
[TBL] [Abstract][Full Text] [Related]
25. [Extensive and radical surgery for primary ovarian cancer].
Chen DX
Zhonghua Fu Chan Ke Za Zhi; 1992 May; 27(3):165-6, 190. PubMed ID: 1327671
[TBL] [Abstract][Full Text] [Related]
26. Mixed mesodermal tumor of the ovary: analysis of prognostic factors in 31 cases.
Barakat RR; Rubin SC; Wong G; Saigo PE; Markman M; Hoskins WJ
Obstet Gynecol; 1992 Oct; 80(4):660-4. PubMed ID: 1328975
[TBL] [Abstract][Full Text] [Related]
27. Ovarian germ cell tumours: a 17-year study in a single unit.
Panteli C; Curry J; Kiely E; Pierro A; de Coppi P; Anderson J; Sebire N; Drake D
Eur J Pediatr Surg; 2009 Apr; 19(2):96-100. PubMed ID: 19360543
[TBL] [Abstract][Full Text] [Related]
28. Morbidity of rectosigmoid resection and primary anastomosis in patients undergoing primary cytoreductive surgery for advanced epithelial ovarian cancer.
Mourton SM; Temple LK; Abu-Rustum NR; Gemignani ML; Sonoda Y; Bochner BH; Barakat RR; Chi DS
Gynecol Oncol; 2005 Dec; 99(3):608-14. PubMed ID: 16153697
[TBL] [Abstract][Full Text] [Related]
29. Feasibility of ovarian preservation in patients with early stage endometrial carcinoma.
Lee TS; Jung JY; Kim JW; Park NH; Song YS; Kang SB; Lee HP
Gynecol Oncol; 2007 Jan; 104(1):52-7. PubMed ID: 16887175
[TBL] [Abstract][Full Text] [Related]
30. Outcome of ovarian cancer patients who underwent incomplete surgical staging.
Panprom P; Lertkhachonsuk R
J Med Assoc Thai; 2008 Sep; 91(9):1323-30. PubMed ID: 18843859
[TBL] [Abstract][Full Text] [Related]
31. Ovarian epithelial tumors of low malignant potential: a case series of 5 adolescent patients.
Aggarwal A; Lucco KL; Lacy J; Kives S; Gerstle JT; Allen L
J Pediatr Surg; 2009 Oct; 44(10):2023-7. PubMed ID: 19853767
[TBL] [Abstract][Full Text] [Related]
32. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
[TBL] [Abstract][Full Text] [Related]
33. Occult bilateral involvement in stage I epithelial ovarian cancer.
Benjamin I; Morgan MA; Rubin SC
Gynecol Oncol; 1999 Mar; 72(3):288-91. PubMed ID: 10053097
[TBL] [Abstract][Full Text] [Related]
34. Comprehensive restaging laparotomy in women with apparent early ovarian carcinoma.
Soper JT; Johnson P; Johnson V; Berchuck A; Clarke-Pearson DL
Obstet Gynecol; 1992 Dec; 80(6):949-53. PubMed ID: 1333065
[TBL] [Abstract][Full Text] [Related]
35. What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)?
Chi DS; Eisenhauer EL; Lang J; Huh J; Haddad L; Abu-Rustum NR; Sonoda Y; Levine DA; Hensley M; Barakat RR
Gynecol Oncol; 2006 Nov; 103(2):559-64. PubMed ID: 16714056
[TBL] [Abstract][Full Text] [Related]
36. [Malignant ovarian germ cell tumours: a trial of 36 cases].
Gueye A; Narducci F; Baranzelli MC; Collinet P; Farine O; Fournier C; Vinatier D; Leblanc E
Gynecol Obstet Fertil; 2007 May; 35(5):406-19. PubMed ID: 17350873
[TBL] [Abstract][Full Text] [Related]
37. Primary ovarian cancer at National Taiwan University Hospital: 1980-1989.
Chen CK; Chow SN; Chen RJ; Chen YP; Huang LC; Wang LI; Lin YH; Huang SC
Int Surg; 1994; 79(1):48-51. PubMed ID: 8063555
[TBL] [Abstract][Full Text] [Related]
38. Secondary cytoreductive surgery in patients presenting with isolated nodal recurrence of epithelial ovarian cancer.
Fotiou S; Aliki T; Petros Z; Ioanna S; Konstantinos V; Vasiliki M; George C
Gynecol Oncol; 2009 Aug; 114(2):178-82. PubMed ID: 19450872
[TBL] [Abstract][Full Text] [Related]
39. Association of lymphadenectomy and survival in stage I ovarian cancer patients.
Chan JK; Munro EG; Cheung MK; Husain A; Teng NN; Berek JS; Osann K
Obstet Gynecol; 2007 Jan; 109(1):12-9. PubMed ID: 17197582
[TBL] [Abstract][Full Text] [Related]
40. Correlation of serum CA125 with stage, grade and survival of patients with epithelial ovarian cancer at a single centre.
Osman N; O'Leary N; Mulcahy E; Barrett N; Wallis F; Hickey K; Gupta R
Ir Med J; 2008 Sep; 101(8):245-7. PubMed ID: 18990955
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]